AI assistant
Sending…
Cellectar Biosciences, Inc. — Director's Dealing 2016
Nov 2, 2016
35021_dirs_2016-11-01_1e4bab72-3a40-435e-b6ee-8a2c40519938.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cellectar Biosciences, Inc. (clrB)
CIK: 0001279704
Period of Report: 2016-08-09
Reporting Person: Hertzberg Richard (significant owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-10-31 | Cellectar Biosciences, Inc. common stock (CLRB) | S | 21000 | $2.029 | Disposed | 280000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-08-09 | Cellectar Biosciences Inc. Warrant (CLRBW) | $46.8 | S | 40916 | Disposed | 2019-08-20 | Cellectar Biosciences, Inc. common stock (CLRB) (40916) | Direct |
Footnotes
F1: CLRB stock sales during period October 13 through October 31, 2016
F2: Price of CLRB at close of market 11/1/2016
More from Cellectar Biosciences, Inc.
Regulatory Filings
2026
May 29
Proxy Solicitation & Information Statement
2026
May 28
Proxy Solicitation & Information Statement
2026
May 28
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 4